Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

3L P Martynova

 

Summary for 2004 [at-glance overview of L P Martynova work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author L P Martynova. According to available data, in 2004 L P Martynova published at least 3 articles. This work was completed in collaboration with several authors including Shmelev, E I and Belianin, I I. Several other authors have collaborated with L P Martynova as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that L P Martynova professional interests are focused around "tuberculosis general health", "pilot areas russia" and "health care facilities". These might also be referred to as "guinea pigs", "mycobacterium tuberculosis" or "enhancing effectiveness". Statistical analysis shows that L P Martynova's writing is likely to contains terms "tuberculosis", "mbt", "esterases", "mice", "guinea" and "pigs".

Unfortunately, there is no affiliation information in L P Martynova articles. Sadly, no email addresses were found for any of the affiliations.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for L P Martynova]

    loading...

    Do you know L P Martynova who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to L P Martynova]

  • none

Year 2004 Charts [L P Martynova frequent coauthors and the most common unique vocabulary terms for the selected year]

  • L P Martynova - Coauthors & Social Network in 2004L P Martynova - Unique Vocabulary, Keywords and Interests in 2004

Historical Performance Charts [graphical overview of L P Martynova publication and funding history for the range of years]

  • L P Martynova - Publications and Funding History in 2004

L P Martynova Coauthors (6) [all coauthors with the number of joint publications]

 

Other [context-specific ads]

Key Opinion Leader In [L P Martynova is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • no keywords assigned

Keywords (24) [keywords assigned to L P Martynova articles by PubMed, the leading number and the color conveys importance]

  • 2Tuberculosis, Pulmonary | 2Mice | 2Mycobacterium tuberculosis | 2Animals | 2Injections, Intraperitoneal | 1Mass Screening | 1Drug Therapy, Combination | 1Tuberculosis, Multidrug-Resistant | 1Injections, Subcutaneous | 1Tuberculosis | 1Prevalence | 1Russia | 1Incidence | 1Ambulatory Care Facilities | 1Humans | 1Pilot Projects | 1Ozone | 1Oxidants, Photochemical | 1Mice, Inbred BALB C | 1Isoniazid | 1Guinea Pigs | 1Solutions | 1Health Services Administration | 1Bacterial Proteins

L P Martynova Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; L P Martynova might be a good expert witness on these terms]

  • 14tuberculosis | 10mbt | 8esterases | 7mice | 6guinea | 6pigs | 6isoniazid | 5control | 5rep | 5po3 | 4mycobacterium | 4medium | 4use | 4experimental | 4patients | 4health | 4diagnosis | 4natural | 3quality | 3effectiveness | 3studies | 3groups | 3ozone | 3lipases | 3enhancing | 3dissolved | 3laboratories | 3resistance | 2provision | 2treated | 2finn-ii | 2died
  • 6guinea pigs | 4mycobacterium tuberculosis | 3enhancing effectiveness | 3lipases esterases | 3dissolved ozone | 3diagnosis tuberculosis | 3pilot areas | 3tuberculosis general | 3general health | 3care facilities | 3health care | 3areas russia | 2control quality | 2esterases inhibit | 2treatment experimental | 2wide range | 2ozone treatment | 2tuberculous process | 2use natural | 2use dissolved | 2tuberculosis mbt | 2tuberculosis mice | 2experimental guinea | 2experimental tuberculosis | 2inhibit mycobacterium | 2range use | 2natural lipases | 2natural esterases | 2resistance mbt | 2case pilot | 2effect rep | 2facilities case
  • 3tuberculosis general health | 3pilot areas russia | 3health care facilities | 3general health care | 3diagnosis tuberculosis general | 2esterases inhibit mycobacterium | 2mycobacterium tuberculosis mbt | 2use dissolved ozone | 2inhibit mycobacterium tuberculosis | 2range use natural | 2dissolved ozone treatment | 2ozone treatment experimental | 2experimental tuberculosis mice | 2experimental guinea pigs | 2natural lipases esterases | 2wide range use | 2use natural lipases | 2treatment experimental tuberculosis | 2lipases esterases inhibit | 2bacterioscopic diagnosis tuberculosis | 2enhancing effectiveness bacterioscopic | 2facilities case pilot | 2drug resistance mbt | 2case pilot areas | 2care facilities case | 2effectiveness bacterioscopic diagnosis | 2ways enhancing effectiveness | 1destruction medium 3-7 | 1treated isoniazid group | 1observed experimental guinea | 1perfect approaches improving | 1researchers central research

Reader's Comments (0) [comments posted by readers of L P Martynova profile]

no comments yet

Funding (0) [selected NIH grants to L P Martynova and the award amounts for recent years]

  • award information is not available

L P Martynova Articles (3) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]

Science Trivia (2) [Interactive math & science trivia questions]